Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: moxa1: Milestone
15
Apr 15, 2008 08:29AM
1
Apr 15, 2008 08:38AM
3
Apr 15, 2008 08:51AM
1
Apr 15, 2008 09:02AM
1
Apr 15, 2008 09:09AM

Apr 15, 2008 09:14AM

Apr 15, 2008 09:16AM
3
Apr 15, 2008 09:41AM

I read the statement to mean, in essence, that the 10Q includes 100% ("fully") of the financial impact of all transactions (including the J3 settlement, if it rises to a "transaction" as I believe it does) announced before February. Ergo, no future income/payments.

Now, does the settlement constitute a "transaction" in this context? I don't know. And the word "fully" bothers me, since it was not qualified or refer to results applicable to the period for which the report was prepared.

Believe me, I want to accept your interpretation, but as Brian and others have noted, it takes some word parsing and leaps of faith to get there, imho. On its face, it seems to say the opposite, at least to me.

Deb

Apr 15, 2008 10:37AM
Share
New Message
Please login to post a reply